Literature DB >> 15642045

Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.

Amit Chattopadhyay1, Daniel J Caplan, Gary D Slade, Diane C Shugars, Hsaio-Chuan Tien, Lauren L Patton.   

Abstract

OBJECTIVES: Oral candidiasis (OC) and oral hairy leukoplakia (OHL) are the most common oral mucosal diseases associated with HIV infection. Independent risk indicators associated with these sentinel opportunistic diseases have not been established in mixed race and gender adult populations in the southeast USA. The purposes of this study were 1) to estimate prevalence of OC and OHL among an HIV-1 positive adult population, and 2) to develop explanatory multivariable models for each disease outcome.
METHODS: This cross-sectional study evaluated 631 adult dentate HIV-1 seropositive persons examined for HIV-associated oral mucosal diseases between 1995 and 2000 at University of North Carolina Hospitals in Chapel Hill, North Carolina using data collected from medical record review, interview questionnaire and clinical examination. We analyzed the data using t-tests, anova, and unconditional logistic regression.
RESULTS: Prevalent OC was associated with low CD4+ cell count [<200 cells/microl, adj. OR = 12.7 (95%CI: 4.9-32.9)], antiretroviral combination therapy [OR = 0.6 (0.3-0.9)], and current smoking [OR = 2.5 (1.3-4.8)]. Prevalent OHL was associated with low CD4+ cell count [<200 cells/microl, OR = 7.2 (2.7-18.9)], antifungal medication use [OR = 1.8 (1.1-2.9)], current recreational drug use [OR = 2.5 (1.3-4.9)], and male gender [OR = 2.5 (1.3-4.8)].
CONCLUSIONS: While CD4+ cell count, and antiretroviral medication were important risk indicators for OC, and OHL, cigarette smoking appears to be an important risk indicator for OC in HIV-1-infected populations. Copyright Blackwell Munksgaard, 2005.

Entities:  

Mesh:

Year:  2005        PMID: 15642045     DOI: 10.1111/j.1600-0528.2004.00194.x

Source DB:  PubMed          Journal:  Community Dent Oral Epidemiol        ISSN: 0301-5661            Impact factor:   3.383


  14 in total

1.  HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.

Authors:  Octavio A González; Mengtao Li; Jeffrey L Ebersole; Chifu B Huang
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

2.  The Influence of Social Support on Smoking Cessation Treatment Adherence Among HIV+ Smokers.

Authors:  Marcel A de Dios; Cassandra A Stanton; Miguel Ángel Cano; Elizabeth Lloyd-Richardson; Raymond Niaura
Journal:  Nicotine Tob Res       Date:  2015-06-26       Impact factor: 4.244

3.  Epidemiological and oral manifestations of HIV-positive patients in a specialized service in Brazil.

Authors:  Erick Nelo Pedreira; Camila Lopes Cardoso; Eder do Carmo Barroso; Jorge André de Souza Santos; Felipe Paiva Fonseca; Luís Antônio de Assis Taveira
Journal:  J Appl Oral Sci       Date:  2008 Nov-Dec       Impact factor: 2.698

Review 4.  Review: the need for smoking cessation among HIV-positive smokers.

Authors:  Shadi Nahvi; Nina A Cooperman
Journal:  AIDS Educ Prev       Date:  2009-06

Review 5.  Oral infectious diseases: a potential risk factor for HIV virus recrudescence?

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Oral Dis       Date:  2009-04-02       Impact factor: 3.511

6.  Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing.

Authors:  Jennifer K Manuel; Paula J Lum; Nicholas S Hengl; James L Sorensen
Journal:  AIDS Care       Date:  2012-11-02

7.  Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis.

Authors:  Job F M van Boven; Lolkje T W de Jong-van den Berg; Stefan Vegter
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

8.  Significant Depletion of CD4(+) T Cells Occurs in the Oral Mucosa during Simian Immunodeficiency Virus Infection with the Infected CD4(+) T Cell Reservoir Continuing to Persist in the Oral Mucosa during Antiretroviral Therapy.

Authors:  Jeffy George; Wendeline Wagner; Mark G Lewis; Joseph J Mattapallil
Journal:  J Immunol Res       Date:  2015-04-30       Impact factor: 4.818

9.  In Vitro Activity of Caspofungin Against Fluconazole-Resistant Candida Species Isolated From Clinical Samples in Iran.

Authors:  Hamideh Shekari Ebrahim Abad; Farideh Zaini; Parivash Kordbacheh; Mahmoud Mahmoudi; Mahin Safara; Vida Mortezaee
Journal:  Jundishapur J Microbiol       Date:  2015-06-27       Impact factor: 0.747

10.  Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates.

Authors:  Janine de Aquino Lemos; Carolina Rodrigues Costa; Crystiane Rodrigues de Araújo; Lúcia Kioko Hasimoto E Souza; Maria do Rosário Rodrigues Silva
Journal:  Braz J Microbiol       Date:  2009-03-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.